All Stories

  1. Targeted Delivery Of Doxorubicin To HER2 Positive Tumor Models [Corrigendum]

    Article • International Journal of Nanomedicine, September 2019, Taylor & Francis

    Hosna Gomari

  2. Targeted delivery of doxorubicin to HER2 positive tumor models

    Article • International Journal of Nanomedicine, July 2019, Dove Medical Press

    Hosna Gomari

  3. Exosome-mediated delivery of functionally active miRNA-142-3p inhibitor reduces tumorigenicity of breast cancer in vitro and in vivo

    Article • International Journal of Nanomedicine, November 2018, Dove Medical Press

    Professor Mahmoud Reza Jaafari, Hosna Gomari, zahra naseri, reza kazemi

  4. Enhanced CD40 and ICOSL expression on dendritic cells surface improve anti-tumor immune responses; effectiveness of mRNA/chitosan nanoparticles

    Article • Immunopharmacology and Immunotoxicology, September 2018, Taylor & Francis

    Hosna Gomari

  5. Targeted cancer therapy using engineered exosome as a natural drug delivery vehicle

    Article • OncoTargets and Therapy, September 2018, Dove Medical Press

    Hosna Gomari

  6. Designing a new biosensor “DNA ELISA” to detect Escherichia coli using genomic DNA and comparison of this method to PCR-ELISA

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, January 2018, Taylor & Francis

    Hosna Gomari